News
Pharmaceutical Technology on MSN8d
AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancerThe approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.
Zacks Investment Research on MSN8d
AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder CancerAstraZeneca AZN announced that the European Commission has approved its blockbuster cancer drug, Imfinzi (durvalumab), for a ...
The US FDA has granted approval for a label update to Eli Lilly and Company's Amyvid (florbetapir F 18 injection) for use intravenously.
An EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback